TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

Table 2

Treatment-related adverse events in patients in response to therapy ().

Sides effects	No. (%) patients associated with adverse events
	Grade 1or 2	Grade 3 or 4
Fever	50 (62.50)	4 (5.00)
Fatigue	18 (22.50)	0
Rash	16 (20.00)	0
Anorexia	12 (15.00)	0
Leukopenia	5 (6.25)	0
Anemia	4 (5.00)	0
Vitiligo	0	0
Nausea	0	0
Vomiting	0	0
Total incidence	69 (86.25)	4 (5.00)